Daily Contraceptive combined pill
The active substances are levonorgestrel and ethinylestradiol. One coated tablet contains 150 micrograms levonorgestrel and 30 micrograms ethinylestradiol.
21 active
Rigevidon is a combined oral contraceptive, also called the pill. It contains two types of female hormones: an oestrogen, ethinylestradiol, and a progestogen, levonorgestrel in a low dose.
The combined contraceptive pill protects you against getting pregnant in three ways. These hormones
1. stop the ovary from releasing an egg each month (ovulation)
2. also thicken the fluid (at the neck of the womb) making it more difficult for the sperm to reach the egg
3. alter the lining of the womb to make it less likely to accept a fertilised egg.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The daily dosage is one coated tablet. You should try to take your pill at about the same time each day. You may find it easiest to take it either last thing at night or first thing in the morning.
Swallow each pill whole, with water if necessary.
Each pack of Rigevidon contains 1 memo strip of 21 coated tablets or 3 memo strips of 21 coated tablets. The memo strip has been designed to help you remember to take your pills.
The pack is marked with the day of the week on which each pill should be taken. Following the direction of the arrow printed on the pack you should take one pill each day for 21 days until the strip is empty.
Then you have 7 days when you do not take a pill. During the 7 pill-free days, on day 2 or 3, you will have menstruation-like withdrawal bleeding, i.e. your monthly period.
Start your next strip on the 8th day (following the 7 pill-free days) – even if the bleeding has not yet ended. As long as you take Rigevidon correctly, you will always start each new strip on the same day of the week, and you will always have your monthly period on the same day of the month.
For more information on starting your first pack, changing to Rigevidon from another contraceptive pill, injection or implant, or starting after childbirth, abortion or miscarriage, read the Rigevidon Package leaflet: Information for the user.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
- Contact a doctor immediately if you experience any of the following symptoms of angioedema: swollen face, tongue and/or throat and/or difficulty swallowing or hives potentially with difficulty breathing (see also section “Warnings and precautions” on the Rigevidon Package leaflet: Information for the user).
- An increased risk of blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)) is present for all women using combined hormonal contraceptives. For more detailed information on the different risks from taking combined hormonal contraceptives please see section 2 “What you need to know before you take Rigevidon” on the Rigevidon Package leaflet: Information for the user).
The following side effects have been reported in women using the pill, which can occur in the first few months after starting Rigevidon, but they usually stop once your body has adjusted to the pill.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Severe allergic reaction (anaphylactic reaction with very rare cases of hives, swelling of face, tongue, severe circulatory and respiratory disorders), glucose intolerance, eye irritation when wearing contact lenses, yellowing of the skin (jaundice), the skin condition erythema nodosum (characterized by painful reddish skin nodules), harmful blood clots in a vein or artery for example:
The chance of having a blood clot may be higher if you have any other conditions that increase this risk (See section 2 for more information on the conditions that increase risk for blood clots and the symptoms of a blood clot).
Very rare side effects (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data)
Inflammatory bowel disease (Crohn’s Disease, ulcerative colitis), hepatocellular injury (e.g. hepatitis, hepatic function abnormal).
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed here.
Enjoy a stress-free consultation without the raised eyebrows.
It only takes 5 minutes to submit your request.